PANBELA THERAPEUTICS ANNOUNCES CLOSING OF $10.0 MILLION BOUGHT DEAL OFFERING OF COMMON STOCKGlobeNewsWire • 07/02/21
Panbela Therapeutics Shares Drop On Raising $10M Via Equity Issued At 21% DiscountBenzinga • 06/30/21
PANBELA THERAPEUTICS INCREASES PREVIOUSLY ANNOUNCED BOUGHT DEAL OFFERING OF COMMON STOCK TO $10.0 MILLIONGlobeNewsWire • 06/30/21
PANBELA THERAPEUTICS ANNOUNCES $5.0 MILLION BOUGHT DEAL OFFERING OF COMMON STOCKGlobeNewsWire • 06/29/21
Panbela Presents Clinical Data on Phase 1b Clinical Trial of SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic PDA at 2021 ASCO Annual MeetingGlobeNewsWire • 06/04/21
Panbela Therapeutics Inc. (PBLA) CEO Jennifer Simpson on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/13/21
Panbela Announces Acceptance of Abstract for Poster Presentation at American Society of Clinical Oncology Annual MeetingGlobeNewsWire • 04/06/21
Corrected: Panbela Provides Business Update and Reports Q4 and FY 2020 Financial ResultsGlobeNewsWire • 03/26/21
Panbela Provides Business Update and Reports Q4 and FY 2020 Financial ResultsGlobeNewsWire • 03/25/21
Panbela Schedules Conference Call on March 25, 2021 to Report 2020 Fourth Quarter Financial ResultsGlobeNewsWire • 03/17/21
Panbela Appoints Industry Veteran, Garry A. Weems, PharmD, as Vice President of Clinical Development & Medical AffairsGlobeNewsWire • 03/15/21
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Panbela Therapeutics Inc. - PBLAPRNewsWire • 02/19/21
DSMB Recommends Hold On SBP-101 Administration In Early-Stage Metastatic Pancreatic Cancer Study, Shares TankBenzinga • 02/10/21
Panbela Announces Research Agreement with Johns Hopkins University School of MedicineGlobeNewsWire • 02/10/21